Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease

Alzheimer’s disease (AD) is a chronic neurodegenerative disorder that accounts for about 60% of all diagnosed cases of dementia worldwide. Although there are currently several drugs marketed for its treatment, none are capable of slowing down or stopping the progression of AD. The role of the blood-...

Full description

Bibliographic Details
Main Author: Del Amo, Laura (author)
Other Authors: Cano, Amanda (author), Ettcheto, Miren (author), Souto, Eliana B. (author), Espina, Marta (author), Camins, Antoni (author), García, Maria Luísa (author), Sánchez-López, Elena (author)
Format: article
Language:eng
Published: 2021
Subjects:
functionalized PLGA nanoparticles
brain delivery
blood-brain barrier
Alzheimer’s disease
Online Access:http://hdl.handle.net/10316/103693
Country:Portugal
Oai:oai:estudogeral.sib.uc.pt:10316/103693

Internet

http://hdl.handle.net/10316/103693

Similar Items